Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Healthtrust
Farmers Insurance
Fish and Richardson
Accenture
Argus Health
Julphar
US Army
US Department of Justice

Generated: July 18, 2018

DrugPatentWatch Database Preview

Levopropoxyphene napsylate anhydrous - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for levopropoxyphene napsylate anhydrous and what is the scope of levopropoxyphene napsylate anhydrous freedom to operate?

Levopropoxyphene napsylate anhydrous
is the generic ingredient in one branded drug marketed by Lilly and is included in one NDA. Additional information is available in the individual branded drug profile pages.

Summary for levopropoxyphene napsylate anhydrous
US Patents:0
Tradenames:1
Applicants:1
NDAs:1
Bulk Api Vendors: 15
Patent Applications: 1
DailyMed Link:levopropoxyphene napsylate anhydrous at DailyMed
Medical Subject Heading (MeSH) Categories for levopropoxyphene napsylate anhydrous
Synonyms for levopropoxyphene napsylate anhydrous
(+)- Propoxyphene napsylate
[(1S,2R)-1-benzyl-3-(dimethylamino)-2-methyl-1-phenyl-propyl] propanoate; naphthalene-2-sulfonic acid
[(2R,3S)-4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-yl] propanoate; naphthalene-2-sulfonic acid
[(2S,3R)-4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-yl] propanoate; naphthalene-2-sulfonic acid
[4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-yl] propanoate; naphthalene-2-sulfonic acid
17140-78-2
2-Butanol, 4-(dimethylamino)-3-methyl-1,2-diphenyl-, propionate (ester), 2-naphthalenesulfonate (salt), (-)-
2-Butanol, 4-(dimethylamino)-3-methyl-1,2-diphenyl-, propionate, 2-naphthalenesulfonate
2-Naphthalenesulfonic acid, compd. with (+)-alpha-(2-dimethylamino)-1-methylethyl-alpha-phenylphenethyl propionate (1:1)
2-Naphthalenesulfonic acid, compd. with (1R,2S)-3-(dimethylamino)-2-methyl-1-phenyl-1-(phenylmethyl)propyl propanoate (1:1)
2-Naphthalenesulfonic acid, compd. with (1S,2R)-3-(dimethylamino) -2-methyl-1-phenyl-1-(phenylmethyl)propyl propanoate (1:1)
2-Naphthalenesulfonic acid, compd. with (S-(R*,S*))-3-(dimethylamino)-2-methyl-1-phenyl-1-(phenylmethyl)p- ropyl propanoate (1:1)
2-NAPHTHALENESULFONIC ACID; PROPOXYPHENE
23239-43-2
5714-90-9
5O7IW35N3C
AC1L1F41
AC1L21TQ
AC1O7GK3
AC1Q6WX8
AN-18686
API0009060
Benzeneethanol, alpha-(2-(dimethylamino)-1-methylethyl)-alpha-phenyl-, propanoate (ester), (1S,2R)-, 2-naphthalenesulfonate (salt)
Benzeneethanol, alpha-(2-(dimethylamino)-1-methylethyl)-alpha-phenyl-, propanoate (ester), (R-(R*,S*))-, 2-naphthalenesulfonate (salt)
Benzeneethanol, alpha-(2-(dimethylamino)-1-methylethyl)-alpha-phenyl-, propanoate (ester), (S-(R*,S*))-, 2-naphthalenesulfonate (salt)
BPBio1_001110
BSPBio_001008
C22H29NO2.C10H8O3S
CAS-5714-90-9
CCG-221054
CHEBI:94397
CHEMBL1237085
CHEMBL1593906
D0HF0W
Darvon N
DSSTox_CID_25563
DSSTox_GSID_45563
DSSTox_RID_80960
DTXSID8045563
EINECS 227-209-1
EINECS 241-205-7
HMS1571C10
HMS2098C10
Levopropoxyphen napsylate
Levopropoxyphene napsilate
Levopropoxyphene Napsylate (anhydrous)
LEVOPROPOXYPHENE NAPSYLATE, ANHYDROUS
Levopropoxyphennapsilat
Levoproxyphene 2-naphthalenesulfonate
LS-175821
LS-94924
N,N,2-trimethyl-3,4-diphenyl-3-(propanoyloxy)butan-1-aminium naphthalene-2-sulfonate
naphthalene-2-sulfonic acid-4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-yl propanoate(1:1)
Naphthalene-2-sulphonic acid, compound with (S-(R*,S*))-1-benzyl-3-(dimethylamino)-2-methyl-1-phenylpropyl propionate (1:1)
NCGC00017048-01
NCGC00180923-01
OR076288
OR076289
Prestwick0_001054
Prestwick1_001054
Prestwick2_001054
Prestwick3_001054
Propoxyphene 2-naphthalenesulfonate
Propoxyphene napsylate
Propoxyphene napsylate (anhydrous)
Propoxyphene napsylate anhydrous
Propoxyphene-N
Regretos
SCHEMBL11674106
SCHEMBL9297768
SPBio_002934
Tox21_110758
UNII-5O7IW35N3C
UNII-W7DQT6KY5S
W7DQT6KY5S

US Patents and Regulatory Information for levopropoxyphene napsylate anhydrous

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly NOVRAD levopropoxyphene napsylate anhydrous SUSPENSION;ORAL 012928-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lilly NOVRAD levopropoxyphene napsylate anhydrous CAPSULE;ORAL 012928-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lilly NOVRAD levopropoxyphene napsylate anhydrous CAPSULE;ORAL 012928-006 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Express Scripts
Accenture
Cerilliant
Cipla
Mallinckrodt
Medtronic
Julphar
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.